Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2006. Start Trial.
Date Value
November 18, 2026 0.3022
November 17, 2026 0.3331
November 16, 2026 0.3579
November 13, 2026 0.3654
November 12, 2026 0.3264
November 11, 2026 0.3197
November 10, 2026 0.3047
November 09, 2026 0.3315
November 06, 2026 0.3254
November 05, 2026 0.3054
November 04, 2026 0.3371
November 03, 2026 0.3409
November 02, 2026 0.4029
October 30, 2026 0.4455
October 29, 2026 0.4533
October 28, 2026 0.4843
October 27, 2026 0.461
October 26, 2026 0.4688
October 23, 2026 0.6237
October 22, 2026 0.8755
October 21, 2026 0.891
October 20, 2026 0.891
October 19, 2026 0.8484
October 16, 2026 0.8407
October 15, 2026 0.9065
Date Value
October 14, 2026 0.8678
October 13, 2026 0.8794
October 12, 2026 0.9763
October 09, 2026 1.030
October 08, 2026 1.050
October 07, 2026 0.953
October 06, 2026 0.9143
October 05, 2026 0.9956
October 02, 2026 1.069
October 01, 2026 1.054
September 30, 2026 1.065
September 29, 2026 0.9229
September 28, 2026 0.8807
September 25, 2026 0.8877
September 24, 2026 0.8807
September 23, 2026 0.9229
September 22, 2026 1.043
September 21, 2026 1.046
September 18, 2026 1.014
September 17, 2026 1.014
September 16, 2026 0.9511
September 15, 2026 0.9617
September 14, 2026 1.029
September 11, 2026 0.9899
September 10, 2026 0.9758

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Anika Therapeutics, Inc. 1.326
MiMedx Group, Inc. 2.185
T2 Biosystems, Inc. --
ABVC BioPharma, Inc. 1.872
Enovis Corp. 1.044

Price to Book Value Related Metrics

PS Ratio 373.59
Price 0.784
Earnings Yield -159.2%
Market Cap 89.50M